Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Tinatin Kuchuloria"'
Autor:
Maia Butsashvili, Tinatin Abzianidze, George Kamkamidze, Lasha Gulbiani, Lia Gvinjilia, Tinatin Kuchuloria, Irina Tskhomelidze, Maka Gogia, Maia Tsereteli, Veronique Miollany, Tamar Kikvidze, Shaun Shadaker, Muazzam Nasrullah, Francisco Averhoff
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background People who inject drugs (PWID) in Georgia have a high prevalence of hepatitis C virus antibody (anti-HCV). Access to care among PWID could be prioritized to meet the country’s hepatitis C elimination goals. This study assesses b
Externí odkaz:
https://doaj.org/article/39abec1820434547a830ec50f7ab5934
Autor:
Josephine G Walker, PhD, Tinatin Kuchuloria, MD, David Sergeenko, MD, Hannah Fraser, PhD, Aaron G Lim, DPhil, Shaun Shadaker, MPH, Liesl Hagan, MPH, Amiran Gamkrelidze, ProfPhD, Valeri Kvaratskhelia, MD, Lia Gvinjilia, MD, Malvina Aladashvili, MD, Alexander Asatiani, MD, Davit Baliashvili, MD, Maia Butsashvili, ProfPhD, Ivdity Chikovani, MD, Irma Khonelidze, MD, Irma Kirtadze, PhD, Mark H Kuniholm, PhD, David Otiashvili, PhD, Lali Sharvadze, PhD, Ketevan Stvilia, MD, Tengiz Tsertsvadze, ProfPhD, Mamuka Zakalashvili, MD, Matthew Hickman, PhD, Natasha K Martin, DPhil, Juliette Morgan, MD, Muazzam Nasrullah, PhD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)
Summary: Background: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up tr
Externí odkaz:
https://doaj.org/article/3bc3fb73a00649c1884f1f75f9adb138
Autor:
Thomas R Laws, Tinatin Kuchuloria, Nazibriola Chitadze, Stephen F Little, Wendy M Webster, Amanda K Debes, Salome Saginadze, Nikoloz Tsertsvadze, Mariam Chubinidze, Robert G Rivard, Shota Tsanava, Edward H Dyson, Andrew J H Simpson, Matthew J Hepburn, Nino Trapaidze
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0148713 (2016)
Several different human vaccines are available to protect against anthrax. We compared the human adaptive immune responses generated by three different anthrax vaccines or by previous exposure to cutaneous anthrax. Adaptive immunity was measured by E
Externí odkaz:
https://doaj.org/article/1cee2b6b032a4d4a878f6ef559889668
Autor:
Khatuna Zakhashvili, Nikoloz Tsertsvadze, Tamar Chikviladze, Ekaterine Jghenti, Marekhi Bekaia, Tinatin Kuchuloria, Matthew J. Hepburn, Paata Imnadze, Alexander Nanuashvili
Publikováno v:
Emerging Infectious Diseases, Vol 16, Iss 8, Pp 1326-1328 (2010)
Externí odkaz:
https://doaj.org/article/416ed4a4f1d1452dbf445c4640966a42
Autor:
Tinatin Kuchuloria, Danielle V. Clark, Matthew J. Hepburn, Tengiz Tsertsvadze, Guillermo Pimentel, Paata Imnadze
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 9, Pp 1489-1491 (2009)
We describe a laboratory-confirmed case of hantavirus infection in the Republic of Georgia. Limited information is available about hantavirus infections in the Caucasus, although the infection has been reported throughout Europe and Russia. Increasin
Externí odkaz:
https://doaj.org/article/6a91ab97493f4071814c516f8787afce
Autor:
Irina Tskhomelidze, Shaun Shadaker, Tinatin Kuchuloria, Lia Gvinjilia, Maia Butsashvili, Muazzam Nasrullah, Tamar Gabunia, Amiran Gamkrelidze, Vladimer Getia, Lali Sharvadze, Tengiz Tsertsvadze, Jaba Zarqua, Shota Tsanava, Senad Handanagic, Paige A. Armstrong, Francisco Averhoff, Peter Vickerman, Josephine G. Walker
Publikováno v:
Tskhomelidze, I, Shadaker, S, Kuchuloria, T, Gvinjilia, L, Butsashvili, M, Nasrullah, M, Gabunia, T, Gamkrelidze, A, Getia, V, Sharvadze, L, Tsertsvadze, T, Zarqua, J, Tsanava, S, Handanagic, S, Armstrong, P A, Averhoff, F, Vickerman, P T & Walker, J G 2022, ' Economic Evaluation of the Hepatitis C Virus Elimination Program in the Country of Georgia, 2015 to 2017 ', Liver International, pp. 1-11 . https://doi.org/10.1111/liv.15431
Background and AimsIn 2015, the country of Georgia launched an elimination program aiming to reduce the prevalence of Hepatitis C virus (HCV) infection by 90% from 5.4% prevalence (~150 000 people). During the first 2.5 years of the program, 770 832
Autor:
Maia Alkhazashvili, Evan M. Bloch, Shaun Shadaker, Tinatin Kuchuloria, Vladimer Getia, Alexander Turdziladze, Paige A. Armstrong, Amiran Gamkrelidze
Publikováno v:
Transfusion Clinique et Biologique.
Autor:
Lia Gvinjilia, Amiran Gamkrelidze, Maia Tsereteli, Ketevan Stvilia, Tinatin Kuchuloria, Vladimer Getia, Irma Khonelidze, Nino Vephkvadze
Publikováno v:
Public Health. 195:42-50
Objectives There is a dearth of research on hepatitis C virus (HCV) treatment uptake among people who inject drugs (PWIDs) and receive methadone substitution treatment (MST) in Eastern Europe and Central Asia countries. This study contributed to addr
Autor:
Maia Butsashvili, Tamar Zurashvili, George Kamkamidze, Maia Kajaia, Lasha Gulbiani, Ana Gamezardashvili, Lia Gvinjilia, Tinatin Kuchuloria, Amiran Gamkrelidze, Shaun Shadaker, Muazzam Nasrullah, Francisco Averhoff, Paige A. Armstrong
Publikováno v:
J Med Screen
Objectives Georgia has a high prevalence of hepatitis C virus (HCV) infection. In 2015 a national HCV elimination program was launched providing free access to screening and treatment. To achieve elimination, innovative approaches to increase screeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13953d6c314ec3cb03c3e9676ddc916
https://europepmc.org/articles/PMC10068592/
https://europepmc.org/articles/PMC10068592/
Autor:
Alexander Turdziladze, Muazzam Nasrullah, Nazibrola Chitadze, Vladimer Getia, Tinatin Kuchuloria, Lia Gvinjilia, Francisco Averhoff, Eteri Kipiani, Sheila M. Keating, Mariam Izoria, Beth Skaggs, Shaun Shadaker, Evan M. Bloch, Amiran Gamkrelidze, Maia Alkhazashvili
Publikováno v:
Transfusion
BACKGROUND: In April 2015, the government of Georgia (country) initiated the world’s first national hepatitis C elimination program. An analysis of blood donor infectious screening data was conducted to inform a strategic plan to advance blood tran